Literature DB >> 10078745

Age-dependent rate of anaplastic transformation in low-grade astrocytoma.

S Shafqat1, E T Hedley-Whyte, J W Henson.   

Abstract

Age and histologic grade are interrelated characteristics of diffuse fibrillary astrocytomas, because the peak age incidence rises with increasing grade. The relationship between age and grade may be explained if age determines the rate of anaplastic progression in astrocytomas. The authors tested this hypothesis by determining the interval between diagnosis of low-grade astrocytoma and progression to high-grade astrocytoma in patients of various ages. A two-way scatterplot of age at initial diagnosis versus interval to anaplastic progression demonstrated a strong negative correlation (n = 24; Pearson correlation coefficient = -0.83; Spearman correlation coefficient = -0.79; p < 0.001 for both values). It was concluded that the rate of anaplastic progression in low-grade astrocytoma is directly correlated with patient age.

Entities:  

Mesh:

Year:  1999        PMID: 10078745     DOI: 10.1212/wnl.52.4.867

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Age at diagnosis and loss of heterozygosity on chromosome 1p and 19q in oligodendroglial tumors.

Authors:  M Hergersberg; L Mariani; E Vassella; C Murtin; J Weis; M Moschopulos; H Laeng; H Landolt; A Huber; U Roelcke
Journal:  J Neurooncol       Date:  2006-05-10       Impact factor: 4.130

2.  Hemorrhagic Recurrence in Diffuse Astrocytoma without Malignant Transformation.

Authors:  Hyun Joo Baek; Seong Min Kim; Seung Young Chung; Moon Sun Park
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

3.  Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.

Authors:  M Kunz; N Thon; S Eigenbrod; C Hartmann; R Egensperger; J Herms; J Geisler; C la Fougere; J Lutz; J Linn; S Kreth; A von Deimling; J C Tonn; H A Kretzschmar; G Pöpperl; F W Kreth
Journal:  Neuro Oncol       Date:  2011-02-03       Impact factor: 12.300

4.  The long-term risk of malignant astrocytic tumors after structural brain injury--a nationwide cohort study.

Authors:  Tina Noergaard Munch; Sanne Gørtz; Jan Wohlfahrt; Mads Melbye
Journal:  Neuro Oncol       Date:  2014-11-21       Impact factor: 12.300

Review 5.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

6.  Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.

Authors:  David A Schomas; Nadia N Laack; Paul D Brown
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

7.  Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic.

Authors:  David A Schomas; Nadia N Issa Laack; Ravi D Rao; Fredric B Meyer; Edward G Shaw; Brian Patrick O'Neill; Caterina Giannini; Paul D Brown
Journal:  Neuro Oncol       Date:  2008-11-18       Impact factor: 12.300

8.  Incidentally found brain tumors in the pediatric population: a case series and proposed treatment algorithm.

Authors:  Erin Wright; Ernest K Amankwah; S Parrish Winesett; Gerald F Tuite; George Jallo; Carolyn Carey; Luis F Rodriguez; Stacie Stapleton
Journal:  J Neurooncol       Date:  2018-11-09       Impact factor: 4.130

9.  Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.

Authors:  Enusha Karunasena; Lauren J McIver; Brian R Rood; Xiaowei Wu; Hongxiao Zhu; Jasmin H Bavarva; Harold R Garner
Journal:  Oncotarget       Date:  2014-08-15

10.  Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.

Authors:  Jane B Cryan; Sam Haidar; Lori A Ramkissoon; Wenya Linda Bi; David S Knoff; Nikolaus Schultz; Malak Abedalthagafi; Loreal Brown; Patrick Y Wen; David A Reardon; Ian F Dunn; Rebecca D Folkerth; Sandro Santagata; Neal I Lindeman; Azra H Ligon; Rameen Beroukhim; Jason L Hornick; Brian M Alexander; Keith L Ligon; Shakti H Ramkissoon
Journal:  Oncotarget       Date:  2014-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.